Gabrielle Emanuel
[Copyright 2024 NPR]
-
New research shows the malaria parasite could be developing resistance to the current front-line treatment for the disease — a drug that has saved millions of lives.
-
Global pandemic treaty negotiators are hashing out cooperation plans this week and considering rushing the process out of fear that the Trump administration would pull the U.S. out of negotiations.
-
The death rate for Marburg virus can be as high as 90%. There are no approved vaccines and treatments. So how did Rwanda achieve what one doctor calls an "unprecedented" success in controlling its outbreak?
-
New reports from Physicians for Human Rights and Doctors Without Borders document a "massive influx" of sexual violence in the eastern Democratic Republic of Congo. What can be done to stop it?
-
Wiping out smallpox had an unintended consequence: the rise of mpox in the past few years. Here's the story — starting with patient zero for mpox back in 1970.
-
Marburg is one scary disease. The fatality rate can be as high as 88%. There's no approved vaccine — yet. With one of the world's largest outbreaks, Rwanda is now testing a promising new vaccine.
-
High levels of lead were found in a surprisingly large number of Bangladeshi kids in New York City — and in pregnant women in Bangladesh. Could there be a common cause?
-
Congo has over 20,000 cases of mpox and hundreds of deaths, mostly in children, but zero vaccines until now. A planeload of doses donated from the EU landed in Kinshasa on Thursday.
-
The U.S. and Europe have access to mpox vaccines, but the epicenter of the current mpox crisis in the Democratic Republic of the Congo has no doses yet.
-
The World Health Organization declared mpox, previously known as monkeypox, a public health emergency. Cases have been surging in the Democratic Republic of Congo, and spread to nearby countries.